KALV leaping 10% today. A quick overview:

Shares of Kalvista Pharmaceuticals Inc (KALV) are trading 10% higher at a price of $16.5 at the time of this writing. The stock's price action is rapidly outpacing it's peers on what is quickly becoming a mildly somber day for the Health Care sector.

The stock is continuing a multi-day upward price move, despite a broad selloff in the great market. Some recent positive news helping to move the stock:

-The New York State Common Retirement Fund has acquired 4,147 shares of KalVista Pharmaceuticals, Inc. (NASDAQ:KALV).
-On Wednesday, August 17th, CEO Thomas Andrew Crockett sold 1,797 shares of the stock at an average price of $14.96, for a total transaction of $26,883.12.
-KalVista Pharmaceuticals' share price crossed above its fifty day moving average during trading last Thursday. The stock has a fifty day moving average of $11.69 and traded as high as $15.33.

Kalvista Pharmaceuticals Inc has been trading between a 52-week high of $21.77 and a 52-week low of $8. The stock has a market cap of $405 Million.

KalVista Pharmaceuticals, Inc. is a pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. KalVista has developed a proprietary portfolio of novel, small molecule plasma kallikrein inhibitors initially targeting hereditary angioedema (HAE) and diabetic macular edema (DME).